StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.12−0.06 (-1.89%)

Close on Nov 18, 2026Market cap $777.47MP/E –Yield –

Ardelyx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Ardelyx's revenue for the twelve months ending Jun 30, 2026 was $450.89M, up 16.8% year over year. For fiscal 2025 it was $407.32M, up 22.1% from the year before. Over ten years it grew 29.1% a year on average. The highest annual figure on record is $407.32M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$407.32M+22.1%
FY2024Dec 31, 2024$333.62M+168.1%
FY2023Dec 31, 2023$124.46M+138.6%
FY2022Dec 31, 2022$52.16M+416.6%
FY2021Dec 31, 2021$10.10M+33.4%
FY2020Dec 31, 2020$7.57M+43.4%
FY2019Dec 31, 2019$5.28M+102.6%
FY2018Dec 31, 2018$2.61M-93.8%
FY2017Dec 31, 2017$42.00M+74.8%
FY2015Dec 31, 2015$24.03M-24.0%
FY2014Dec 31, 2014$31.62M+9.3%
FY2013Dec 31, 2013$28.93M+434.7%
FY2012Dec 31, 2012$5.41M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$120.88M+23.8%
Q1 FY2026Mar 31, 2026$94.47M+27.5%
Q4 FY2025Dec 31, 2025$125.22M+7.8%
Q3 FY2025Sep 30, 2025$110.33M+12.3%
Q2 FY2025Jun 30, 2025$97.66M+33.4%
Q1 FY2025Mar 31, 2025$74.11M+61.0%
Q4 FY2024Dec 31, 2024$116.13M+237.9%
Q3 FY2024Sep 30, 2024$98.24M+74.2%
Q2 FY2024Jun 30, 2024$73.22M+227.9%
Q1 FY2024Mar 31, 2024$46.02M+304.8%
Q4 FY2023Dec 31, 2023$34.36M-22.2%
Q3 FY2023Sep 30, 2023$56.39M+1031.0%
Q2 FY2023Jun 30, 2023$22.33M+784.1%
Q1 FY2023Mar 31, 2023$11.37M+2329.3%
Q4 FY2022Dec 31, 2022$44.18M+4193.3%
Q3 FY2022Sep 30, 2022$4.99M+325.1%
Q2 FY2022Jun 30, 2022$2.53M+92.4%
Q1 FY2022Mar 31, 2022$468.00K-92.9%
Q4 FY2021Dec 31, 2021$1.03M-43.1%
Q3 FY2021Sep 30, 2021$1.17M-56.8%
Q2 FY2021Jun 30, 2021$1.31M-28.5%
Q1 FY2021Mar 31, 2021$6.58M+442.6%
Q4 FY2020Dec 31, 2020$1.81M-19.6%
Q3 FY2020Sep 30, 2020$2.71M-10.0%
Q2 FY2020Jun 30, 2020$1.84M+10100.0%
Q1 FY2020Mar 31, 2020$1.21M+1327.1%
Q4 FY2019Dec 31, 2019$2.25M+1208.1%
Q3 FY2019Sep 30, 2019$3.01M+9943.3%
Q2 FY2019Jun 30, 2019$18.00K-99.2%
Q4 FY2018Dec 31, 2018$85.00K-99.8%
Q3 FY2018Sep 30, 2018$172.00K–
Q2 FY2018Jun 30, 2018$30.00K–
Q1 FY2018Mar 31, 2018$2.32M–
Q4 FY2017Dec 31, 2017$42.00M–

More Ardelyx figures

See a number that looks wrong?